Repligen (RGEN) - Stock Price & Dividends

Repligen Corporation, traded on the NASDAQ under the symbol RGEN, is a leader in developing and commercializing bioprocessing technologies and systems for biological drug manufacturing worldwide. Their innovative products are utilized by life sciences, biopharmaceutical, and diagnostics companies, as well as laboratory researchers and contract manufacturing organizations.

One of their flagship offerings includes Protein A ligands, integral components used in Protein A affinity chromatography resins for biologics purification. Additionally, Repligen provides cell culture growth factor products and a wide range of chromatography solutions, like OPUS pre-packed columns for bioprocessing and smaller-scale columns for process development and validation.

The company's product portfolio extends to ELISA test kits, chromatography resins branded CaptivA, filtration solutions like XCell Alternating Tangential Flow systems and TangenX flat sheet cassettes for biologic drug concentration and buffer exchange processes.

Furthermore, Repligen offers process analytics tools, such as slope spectroscopy systems under various brands like SoloVPE and FlowVPX. They collaborate with partners like Navigo Proteins GmbH to develop unique affinity ligands, showcasing their commitment to innovation and excellence in the bioprocessing industry.

Founded in 1981, Repligen Corporation is headquartered in Waltham, Massachusetts. To learn more about their cutting-edge solutions, visit their official website at https://www.repligen.com.